The molecular revolution in tuberculosis (TB) diagnosis has ushered in a new era of patient
treatment that is quicker, more accurate, and clinically appropriate. In cases where treatment …

About a quarter of the world's population is infected with tuberculosis (TB), with new infection
occurring every second. The global burden, particularly with multidrug resistance, is also …

Background: Tuberculosis (TB) is one of the deadliest threats today; TB due to
Mycobacterium tuberculosis (MTB) remains a major public health issue: the infection affects …

BACKGROUND Tuberculosis (TB) is an ancient disease of mankind. TB is an infectious and
contagious disease. TB is caused by Mycobacterium tuberculosis (MT). MT has very ancient …

Background: Mycobacterium tuberculosis remains one of the most significant causes of
death from an infectious agent. The rapid diagnosis of tuberculosis and detection of …

Objectives Vietnam is a high-prevalence country for tuberculosis (TB). Xpert MTB/RIF is a
novel PCR-based diagnostic test that is substantially more sensitive for detecting M …

Background: Tuberculosis (TB) is one of the most common and deadly infectious diseases in
humans. Due to widespread poverty, inequity, and conflict, suboptimal health services in …

The diagnostic efforts for extrapulmonary tuberculosis (TB) have been severely hampered
by the lack of diagnostic tests that are accurate, simple to use and can be applied at the …

Background: Tuberculosis (TB) is the world's serious public health issue with a burden of
estimated 8.7 million new cases and 1.4 million deaths annually. A significant problem in …

Molecular technology revolutionized the diagnosis of tuberculosis (TB) with a paradigm shift
to faster, more sensitive, clinically relevant patient care. The most recent molecular leader is …